Sleeping under 7 hours accelerates aging and cuts lifespan — what the OHSU data shows.

The OHSU study — what it found and how

In December 2025, researchers from Oregon Health & Science University published an analysis in SLEEP Advances that covered 3,141–3,143 U.S. counties across all 50 states over a six-year period (2019–2025). The data source was the CDC's Behavioral Risk Factor Surveillance System (BRFSS), one of the largest ongoing health behavior surveys in the world [1].

The finding that drew national attention: insufficient sleep — defined as regularly sleeping under 7 hours per night — was significantly negatively correlated with life expectancy across most U.S. states throughout the full observation period. Critically, the association held after controlling for other major lifestyle factors.

When insufficient sleep was ranked against established health risk factors, it was a stronger predictor of reduced life expectancy than diet quality, physical inactivity, and social isolation. Only smoking showed a stronger independent association in the primary model; when obesity and diabetes were entered as additional variables, obesity also ranked above sleep insufficiency. Across all models, sleep remained ahead of diet, inactivity, and social isolation. This is not a marginal finding — ranking second or third to smoking in a controlled population-level analysis is a substantial signal [1].

The study's lead author, Kathryn McAuliffe of OHSU's School of Nursing, framed it plainly: "Sleep insufficiency is not a minor lifestyle issue. It's among the most significant modifiable predictors of how long people live."

The county-level design is worth understanding. Rather than tracking individuals over time (a cohort study), this analysis used county-level prevalence of insufficient sleep and correlated it with county-level life expectancy data. The strength is the scale — over 3,000 geographic units, six years of data, population-level controls. The limitation is that county-level correlations cannot establish individual-level causation in the same way a randomized controlled trial would. But for a variable like sleep duration, which cannot be randomized long-term, large observational designs at this scale are the practical ceiling of the evidence available.

Among modifiable risk factors, only smoking — and in some model specifications, obesity — outranks chronic short sleep as a predictor of how soon you die. It still beats inactivity, diet quality, and social isolation.

GH pulsatility — what sleep deprivation breaks

Human growth hormone (GH) is not secreted continuously. It is released in pulses — primarily during the first hours of slow-wave sleep (SWS), also called deep sleep or N3 sleep. In healthy adults, the largest GH pulse of any 24-hour period occurs shortly after sleep onset, during the first deep sleep cycle. This is not an evolutionary accident: GH is a repair signal, and the body times its peak release for the period of maximal physical inactivity and anabolism [2, 13].

In adults, GH drives tissue repair, fat metabolism (lipolysis), lean mass maintenance, immune modulation, and multiple markers of cellular health. It is one of the primary signals the body uses to preserve organ and tissue integrity across decades — which is exactly the framework that matters for aging [3].

Sleep restriction disrupts this pulsatile architecture in two ways. First, it reduces total time in slow-wave sleep, directly cutting the window during which the largest GH pulse occurs. Second, it elevates somatostatin — a GH-inhibiting hormone — in response to cortisol elevation from sleep disruption, further suppressing GH output even during the SWS that does occur. The result: chronic short sleepers have significantly lower 24-hour GH exposure than adequate sleepers, even if they're not clinically GH-deficient by traditional criteria [2, 3].

This is directly relevant to the aging picture. GH decline is one of the defining characteristics of biological aging — somatopause, the age-related reduction in GH secretion, is associated with body composition deterioration, immune dysfunction, and reduced resilience. Chronic sleep restriction effectively accelerates somatopause by truncating the main physiological driver of GH output: the deep sleep pulse. The deep sleep and GH relationship is one of the most well-characterized endocrine-sleep interactions in the literature.

Cortisol dysregulation — the chronic alarm signal

Cortisol follows a circadian rhythm: it peaks shortly after waking (the cortisol awakening response, or CAR) and declines over the day, reaching its nadir in the first half of the night. This pattern is not just a scheduling convenience — it is the primary regulator of daily energy mobilization, immune function timing, and the body's anti-inflammatory response. When the cortisol rhythm is intact, it suppresses inflammation acutely and resets it daily [4].

Sleep restriction disrupts this architecture in well-documented ways. Studies by Spiegel, Van Cauter, and colleagues at the University of Chicago have shown that partial sleep restriction (restricting adults to 4–6 hours over multiple nights) dampens the amplitude of the circadian cortisol decline — meaning evening cortisol stays elevated when it should be falling. This produces a flattened cortisol curve that the body interprets as a state of chronic, unresolved stress [4, 5].

Chronically elevated evening cortisol has downstream consequences that compound over years: accelerated hippocampal volume loss (cortisol is neurotoxic to hippocampal neurons at sustained exposure), insulin resistance (cortisol is a potent glucocorticoid that drives hepatic glucose production and reduces peripheral insulin sensitivity), visceral fat accumulation (cortisol redirects fat storage toward the abdomen), and immune suppression. Each of these is an independent driver of biological aging at the cellular and systemic level [5, 6].

The stress-fat connection is covered in the cortisol and weight gain analysis. The sleep angle is the upstream driver that most discussions of that topic underweigh. You cannot fix cortisol dysregulation with adaptogens and breathwork if you are chronically under-sleeping — the physiological input (sleep architecture) is the primary regulator, not a secondary one.

Chronic inflammation — the accelerant

Sleep is the period during which the glymphatic system — the brain's waste-clearance network — is most active. During deep sleep, interstitial space in the brain expands significantly, allowing cerebrospinal fluid (CSF) to flush metabolic waste products including amyloid-beta and tau protein. Sleep deprivation impairs this process, and chronic impairment is associated with accumulation of inflammatory markers across multiple systems [7].

The inflammatory biomarker evidence is consistent. Sleep restriction studies consistently show elevated circulating levels of C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α) in groups sleeping under 6–7 hours compared to adequate sleepers. These are not subtle effects — in some studies, sleeping 6 hours or less was associated with CRP levels comparable to those seen in individuals with clinically significant inflammatory conditions [8].

Chronic low-grade inflammation (inflammaging) is one of the primary mechanisms through which biological aging accelerates. It drives endothelial dysfunction, impairs immune surveillance of pre-malignant cells, promotes insulin resistance, and degrades mitochondrial function. Sleep deprivation is among the most reliable and modifiable drivers of this process in otherwise healthy adults.

It also creates a self-reinforcing loop: elevated inflammatory cytokines impair sleep architecture, particularly deep sleep and REM sleep. Poor sleep raises inflammation. Inflammation impairs sleep further. In chronic short sleepers, this cycle can entrench over years without a single significant disruptive event to trace it back to.

Epigenetic aging — how sleep shows up on your biological clock

Epigenetic clocks — most notably the Horvath clock, the Hannum clock, and the GrimAge clock — measure biological age by analyzing DNA methylation patterns at specific genomic sites. These sites change predictably with age, and the pace of change correlates with outcomes like mortality, disease incidence, and functional decline more accurately than chronological age alone [9].

The sleep-epigenetic aging relationship has been studied in multiple cohorts. The consistent finding: adults who chronically sleep under 7 hours show accelerated epigenetic aging relative to adequate sleepers, even after controlling for confounders including physical activity, diet quality, smoking, and alcohol. In some studies, short sleep (<6 hours) is associated with a biological age roughly 1.4–1.5 years older than adequate sleepers by GrimAge measurement — a cross-sectional difference that, if it accumulates longitudinally, would represent meaningful acceleration over decades of chronic restriction [9, 10].

The mechanism is not fully characterized, but the proposed pathways include cortisol's known effects on DNA methylation, inflammatory cytokine modulation of epigenetic marks, and reduced GH exposure affecting histone modification patterns. All three pathways converge on the same outcome: the cellular and molecular markers of age advance faster when sleep is chronically restricted.

Telomere length, another marker of biological aging, also shows association with sleep quality. Studies examining leukocyte telomere length in adults find shorter telomeres in chronically poor sleepers, with the association strongest for sleep quality measures (sleep efficiency, frequency of awakenings) rather than duration alone — suggesting that sleep architecture matters, not just clock time in bed [10].

Cardiovascular and metabolic damage downstream

The lifespan reduction in the OHSU data reflects, in large part, cardiovascular and metabolic disease pathways. Both are well-characterized downstream effects of chronic sleep restriction.

A comprehensive meta-analysis found that sleeping under 6 hours per night was associated with a 48% increased risk of developing or dying from coronary heart disease and a 15% increased risk of stroke, compared to 7–8 hour sleepers [11]. These associations hold after adjustment for known cardiovascular risk factors, suggesting sleep operates through mechanisms independent of — or in addition to — hypertension, dyslipidemia, and obesity. The overlap with sauna-related cardiovascular mortality reduction is notable: both act partly through autonomic balance and vascular endothelial pathways.

The metabolic pathways are equally concrete. The Spiegel-Van Cauter experiments showed that six days of sleep restriction to 4 hours per night significantly reduced glucose tolerance — an effect the authors described as resembling changes associated with normal aging and increased diabetes risk. Effects partially recovered with sleep restoration but did not fully reverse within the study period [5]. Leptin (the satiety signal) fell 18% and ghrelin (the hunger signal) rose 28% during restriction, driving caloric intake increases that compound the metabolic damage over time.

None of these mechanisms operate in isolation. Cortisol elevates blood glucose. Elevated glucose impairs vascular endothelium. Impaired endothelium raises cardiovascular risk. Inflammation accelerates all of it. The sleep debt and metabolic damage article covers this cascade in detail. The OHSU lifespan data represent, in essence, the population-level outcome of these individual mechanisms operating across millions of adults over years.

What the evidence supports doing about it

The interventions with the strongest evidence for improving sleep quality and duration are, in order of effect size: sleep restriction therapy (also called cognitive behavioral therapy for insomnia, CBT-I), consistent sleep-wake scheduling, light management, and a shorter list of supplements.

Consistent timing matters more than most people realize. Circadian rhythm consistency — waking at the same time daily, including weekends — is a more powerful driver of sleep quality than bedtime. Social jetlag (sleeping 2+ hours later on weekends than weekdays) is associated with metabolic dysfunction and inflammation independent of total sleep time.

Light is the primary circadian signal. Morning bright light (ideally outdoor light, 10–30 minutes within an hour of waking) anchors the circadian clock and advances the sleep drive earlier. Evening blue light suppression (screens, overhead LED lighting) in the 2 hours before bed reduces the melatonin suppression that delays sleep onset.

On supplements, the evidence is narrow. The magnesium RCT data is the most credible in this category — magnesium glycinate or threonate at 200–400 mg in the 1–2 hours before bed improves subjective sleep quality and reduces sleep onset latency in magnesium-insufficient adults. The evidence for melatonin is specifically for circadian rhythm disorders (jet lag, delayed sleep phase) at low doses (0.5–1 mg), not for general sleep improvement in euthymic adults.

The sleep supplement stack question is frequently overcomplicated. Sleep hygiene (timing, light, temperature, alcohol elimination) accounts for the majority of variance in sleep quality in otherwise healthy adults. Supplements address the margin, not the foundation.

The OHSU data's practical implication is not that you need a 9-hour sleep protocol or to optimize sleep architecture with expensive devices. It is simpler: getting 7–9 hours consistently is among the highest-return health behaviors available to most adults — outranking, by the data, several interventions the wellness industry prices far more highly.

References

1. McAuliffe KE, Wary MR, Pleas GV, et al. Sleep insufficiency and life expectancy at the state-county level in the United States, 2019-2025. SLEEP Advances. 2025;6(4):zpaf090. doi:10.1093/sleepadvances/zpaf090. PMID:41445723
2. Van Cauter E, Leproult R, Plat L. Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men. JAMA. 2000;284(7):861-868. doi:10.1001/jama.284.7.861
3. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998;19(6):717-797. doi:10.1210/edrv.19.6.0353
4. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep. 1997;20(10):865-870. doi:10.1093/sleep/20.10.865
5. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354(9188):1435-1439. doi:10.1016/S0140-6736(99)01376-8
6. Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846-850. doi:10.7326/0003-4819-141-11-200412070-00008
7. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377. doi:10.1126/science.1241224
8. Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: a systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biol Psychiatry. 2016;80(1):40-52. doi:10.1016/j.biopsych.2015.05.014
9. Liang G, Beydoun MA, Hossain S, et al. Accelerated epigenetic aging and incident sleep disturbances in the Atherosclerosis Risk in Communities study. Sleep. 2021;44(3):zsaa152. doi:10.1093/sleep/zsaa152
10. Carroll JE, Esquivel S, Goldberg A, et al. Insomnia and telomere length in older adults. Sleep. 2016;39(3):559-564. doi:10.5665/sleep.5526
11. Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484-1492. doi:10.1093/eurheartj/ehr007
12. Ungvari Z, Fekete M, Varga P, et al. Sleep dysfunction and accelerated aging: mechanisms and therapeutic targets. Geroscience. 2025. doi:10.1007/s11357-025-01539-y
13. Van Cauter E, Plat L. Physiology of growth hormone secretion during sleep. J Pediatr. 1996;128(5 Pt 2):S32-S37. doi:10.1016/S0022-3476(96)70008-2. PMID:8627466